Efficacy of prophylactic intravenous ondansetron on the prevention of hypotension during cesarean delivery: A dose-dependent study

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 12, 2014, Pages 5210-5216

  Wang, Meng ^a   Zhuo, Lang ^b   Wang, Qun ^a   Shen, Ming Kun ^a   Yu, Yan Yun ^a   Yu, Jun Jing ^a   Wang, Zhi Ping ^c  

^a The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Hypotension; Ondansetron; Optimal dose; Spinal anesthesia

Indexed keywords

ONDANSETRON; OXYTOCIN; PHENYLEPHRINE;

ADULT; ARTICLE; BLOOD CARBON DIOXIDE TENSION; BRADYCARDIA; CESAREAN SECTION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FETUS OUTCOME; HEART RATE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MATERNAL HYPOTENSION; MEAN ARTERIAL PRESSURE; NAUSEA; OPERATIVE BLOOD LOSS; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SPINAL ANESTHESIA; SYSTOLIC BLOOD PRESSURE; UMBILICAL CORD BLOOD; VOMITING;

EID: 84921500603     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Stewart A, Fernando R, McDonald S, Hignett R, Jones T, Columb M. The dose-dependent effects of phenylephrine for elective cesarean delivery under spinal anesthesia. Anesth Analg 2010; 111: 1230-1237.
2. Warwick D. Ngan Kee. Prevention of maternal hypotension after regional anesthesia for caesarean section. Curr Opin Anaesthesiol 2010; 23: 304-309.
3. Sahoo T, SenDasgupta C, Goswami A, Hazra A. Reduction in spinal-induced hypotension with ondansetron in parturients undergoing caesarean section: A double-blind randomised, placebo-controlled study. Int J Obstet Anesth 2012; 21: 24-28.
4. Wang Q, Zhuo L, Shen MK, Yu YY, Yu JJ, Wang M. Ondansetron Preloading with Crystalloid Infusion Reduces Maternal Hypotension during Cesarean Delivery. Am J Perinatol 2014; 10: 913-922.
5. Christofaki M, Papaioannou A. Ondansetron: a review of pharmacokinetics and clinical experience in postoperative nausea and vomiting. Expert Opin Drug Metab Toxicol 2014; 10: 437-444.
6. Yeh YC, McDonnell A, Klinger E, Fowler B, Ma-tta L, Voit D, Reddy P. Comparison of healthcare resource use between patients receiving ondansetron or palonosetron as prophylaxis for chemotherapy-induced nausea and vomiting. J Oncol Pharm Pract 2011; 17: 179-185.
7. Goodin S, Cunningham R. 5-HT(3)-receptor antagonists for the treatment of nausea and vomiting: a reappraisal of their side-effect profile. Oncologist 2002; 7: 424-436.
8. Martinek RM. Witnessed asystole during spinal anesthesia treated with atropine and ondansetron: a case report. Can J Anesth 2004; 51: 226-230.
9. Gyermek L. Pharmacology of serotonin as related to anesthesia. J Clin Anesth 1996; 8: 402-405.
10. Mao HZ, Chapleu MW. Platelet activation in carotid sinuses triggers sympathoinhibition and hypotension. Hypertension 1996; 27: 584-590.
11. Aviado DM, Guevara Aviado D. The Bezold-Jarisch reflex: a historical perspective of cardiopulmonary reflexes. Ann N Y Acad Sci 2001; 940: 48-58.
12. Pasternak B, Svanström H, Hviid A. Ondanse-tron in Pregnancy and Risk of Adverse Fetal Outcomes. N Engl J Med 2013; 368: 2146.
13. Einarson A, Maltepe C, Navioz Y, Kennedy D, Tan MP, Koren G. The safety of ondansetron for nausea and vomiting of pregnancy a prospective comparative study. BJOG 2004; 111: 940-943.
14. Spiegel JE, Kang V, Kunze L, Hess P. Ondan-setron-induced extrapyramidal symptoms during cesarean section. Int J Obstet Anesth 2005; 14: 368-369.
15. Cherian A, Maguire M. Transient blindness following intravenous ondansetron. Anaesthesia 2005; 60: 938-939.
16. Charbit B, Albaladejo P, Funck-Brentano C, Le-grand M, Samain E, Marty J. Prolongation of QTc Interval after Postoperative Nausea and Vomiting Treatment by Droperidol or Ondanse-tron. Anesthesiology 2005; 102: 1094-1100.
17. Charbit B, Alvarez JC, Dasque E, Abe E, Démolis JL, Funck-Brentano C. Droperidol and ondansetron-induced QT interval prolongation:a clinical drug interaction study. Anesthesiology 2008; 109: 206-212
18. McKechnie K, Froese A. Ventricular tachycardia after ondansetron administration in a child with undiagnosed long QT syndrome. Can J Anaesth 2010; 57: 453-457.
19. Havrilla PL, Kane-Gill SL, Verrico MM, Seybert AL, Reis SE. Coronary Vasospasm and Atrial Fi-brillation Associated with Ondansetron Thera-py. Ann Pharmacother 2009; 43: 532-536.
20. Chandrakala R, Vijayashankara CN, Kumar KK, Sarala N. Ondansetron induced fatal ventricular tachycardia. Indian J Pharmacol 2008; 40: 186-187.
21. Singh V, Sinha A, Prakash N. Ondansetron-induced migraine-type headache. Can J Ana-esth 2010; 57: 872-873.
22. Johannsen S, Roewer N, Schuster F. Ondanse-tron-Induced Muscular Contractures in Malig-nant Hyperthermia-Susceptible Individuals. Anesth Analg 2012; 111: 925-928.
23. Owczuk R, Wenski W, Polak-Krzeminska A, Tw-ardowski P, Arszułowicz R, Dylczyk-Sommer A, Wujtewicz M., Sawicka W, Morzuch E, Smie-tanski M, Wujtewicz M. Ondansetron given intravenously attenuates arterial blood pressure drop due to spinal anesthesia: a double-blind, placebo-controlled study. Reg Anesth Pain Med 2008; 33: 332-339.